The role of mTOR inhibition in augmenting radiation induced autophagy

Jerry J Jaboin1, Eric T Shinohara, Luigi Moretti

  • 1Department of Radiation Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA.

Insights

Targeting the mammalian target of rapamycin (mTOR) pathway with inhibitors may enhance radiation therapy by promoting autophagy. Further research is needed to identify optimal tumor types for this combined approach.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy

Background:

  • Radiation therapy effectiveness is limited by damage to normal tissues, necessitating strategies to improve the therapeutic ratio.
  • Autophagy, a cellular process involved in both cell death and survival, plays a complex role in solid tumors.
  • The mammalian target of rapamycin (mTOR) pathway regulates autophagy, cell survival, and proliferation, presenting a potential therapeutic target.

Purpose of the Study:

  • To investigate the potential of targeting the mTOR pathway to enhance the efficacy of radiation therapy.
  • To explore the role of mTOR inhibition in modulating autophagy in the context of cancer treatment.
  • To determine if combining mTOR inhibitors with radiation can improve therapeutic outcomes.

Main Methods:

  • Investigated the effects of mTOR inhibitors on autophagy.
  • Examined the combined effects of mTOR inhibitors and radiation therapy in preclinical models.
  • Analyzed the induction of autophagy in response to mTOR inhibition and radiation across different tumor types.

Main Results:

  • Direct inhibition of autophagy has variable effects on cancer cell fate, depending on cell type and conditions.
  • mTOR inhibitors show promise in combination with radiation, potentially potentiating radiation-induced autophagy.
  • Further studies are required to identify specific tumor types that exhibit robust autophagy induction with mTOR inhibition and radiation.

Conclusions:

  • Targeting the mTOR pathway offers a promising strategy to enhance radiation therapy by modulating autophagy.
  • Combination therapy with mTOR inhibitors and radiation may improve cancer treatment outcomes.
  • Identifying tumors with the strongest autophagic response to this combination is crucial for clinical application.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...